ZIVO Bioscience, Inc. (ZIVO)
OTCMKTS · Delayed Price · Currency is USD
3.112
-0.488 (-13.54%)
Sep 8, 2026, 3:29 PM EST
ZIVO Bioscience Market Cap
ZIVO Bioscience has a market cap or net worth of $12.92 million as of September 8, 2026. Its market cap has decreased by -77.20% in one year.
Market Cap
12.92M
Enterprise Value
13.68M
Revenue
209.03K
Ranking
n/a
PE Ratio
n/a
Stock Price
$3.11
ChartMarket Cap Chart
Since October 30, 2003, ZIVO Bioscience's market cap has increased from 2.41M to 12.92M, an increase of 435.42%. That is a compound annual growth rate of 7.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 12.92M | -62.30% |
| Dec 31, 2025 | 34.27M | -55.05% |
| Dec 31, 2024 | 76.25M | 3,046.50% |
| Dec 29, 2023 | 2.42M | -89.71% |
| Dec 30, 2022 | 23.55M | -12.89% |
| Dec 31, 2021 | 27.03M | -56.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Provectus Biopharmaceuticals | 25.22M |
| Biomind Labs | 19.42M |
| EOM Pharmaceuticals Holdings | 19.11M |
| Finch Therapeutics Group | 16.62M |
| Anebulo Pharmaceuticals | 14.63M |
| Oncotelic Therapeutics | 14.34M |
| Synlogic | 13.69M |
| Inhibitor Therapeutics | 12.87M |